Previous Page  19 / 42 Next Page
Information
Show Menu
Previous Page 19 / 42 Next Page
Page Background

N=77

CheckMate 012: F1, 1L

Nivolumab + Ipilimumab

RR: 47%

RR: 38%

TMB (WES)